Elixirr International PLC
LSE:ELIX

Watchlist Manager
Elixirr International PLC Logo
Elixirr International PLC
LSE:ELIX
Watchlist
Price: 780 GBX 1.3% Market Closed
Market Cap: 375.9m GBX
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ELIX stock under the Base Case scenario is 728.92 GBX. Compared to the current market price of 780 GBX, Elixirr International PLC is Overvalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ELIX Relative Value
Base Case
728.92 GBX
Overvaluation 7%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.4
P/S
P/S
Price to Sales
3.4
vs History
28
vs Industry
21
Median 3Y
3.3
Median 5Y
3.1
Industry
1.3
Forward
2.7
More Details
23
P/E
P/E
Price to Earnings
23
vs History
18
vs Industry
35
Median 3Y
18.3
Median 5Y
16.8
Industry
19.2
Forward
15.9
More Details
12.8
P/OCF
P/OCF
Price to OCF
12.8
vs History
55
vs Industry
28
Median 3Y
15
Median 5Y
13.7
Industry
13
More Details
15.6
P/FCFE
P/FCFE
Price to FCFE
15.6
vs History
55
vs Industry
28
Median 3Y
20.9
Median 5Y
16.9
Industry
18.6
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
33
vs Industry
35
Median 3Y
2.5
Median 5Y
2.5
Industry
2.4
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
23
vs Industry
21
Median 3Y
3.1
Median 5Y
2.9
Industry
1.4
Forward
2.6
More Details
10.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.4
vs History
23
vs Industry
14
Median 3Y
9.5
Median 5Y
8.8
Industry
3.4
More Details
13
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13
vs History
23
vs Industry
28
Median 3Y
11.5
Median 5Y
10.9
Industry
10.2
Forward
9.9
More Details
15
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15
vs History
23
vs Industry
33
Median 3Y
13.5
Median 5Y
12.5
Industry
13.5
Forward
11.7
More Details
12.7
EV/OCF
EV/OCF
Enterprise Value to OCF
12.7
vs History
51
vs Industry
27
Median 3Y
14.1
Median 5Y
12.8
Industry
12.4
More Details
12.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
12.8
vs History
51
vs Industry
29
Median 3Y
14.3
Median 5Y
13
Industry
14.9
More Details
2.6
EV/IC
EV/IC
Enterprise Value to IC
2.6
vs History
31
vs Industry
30
Median 3Y
2.2
Median 5Y
2.3
Industry
1.7
More Details

Multiples Across Competitors

ELIX Competitors Multiples
Elixirr International PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Elixirr International PLC
LSE:ELIX
376.3m GBP 3.4 23 13 15
UK
Relx PLC
LSE:REL
74.1B GBP 7.9 38.3 22 28.1
CA
Thomson Reuters Corp
TSX:TRI
122.8B CAD 12.3 41.5 30.5 42.6
IE
Experian PLC
LSE:EXPN
33.7B GBP 6 39 163.5 229.8
US
Verisk Analytics Inc
NASDAQ:VRSK
44B USD 15 45.3 29 36.1
UK
IHS Markit Ltd
F:0M3
37.9B EUR 9.3 35.7 26.4 39.5
NL
Wolters Kluwer NV
AEX:WKL
36.6B EUR 6.2 33.9 20.5 27.3
US
Equifax Inc
NYSE:EFX
32.8B USD 5.7 53.6 21.2 35.1
US
CoStar Group Inc
NASDAQ:CSGP
31.1B USD 11.1 265.7 170.1 5 870.9
CH
SGS SA
SIX:SGSN
16.2B CHF 2.4 27.9 13.1 20
US
Leidos Holdings Inc
NYSE:LDOS
19B USD 1.1 14.3 10.5 12
P/E Multiple
Earnings Growth PEG
UK
Elixirr International PLC
LSE:ELIX
Average P/E: 56.2
23
N/A N/A
UK
Relx PLC
LSE:REL
38.3
16%
2.4
CA
Thomson Reuters Corp
TSX:TRI
41.5
1%
41.5
IE
Experian PLC
LSE:EXPN
39
22%
1.8
US
Verisk Analytics Inc
NASDAQ:VRSK
45.3
10%
4.5
UK
I
IHS Markit Ltd
F:0M3
35.7
N/A N/A
NL
Wolters Kluwer NV
AEX:WKL
33.9
10%
3.4
US
Equifax Inc
NYSE:EFX
53.6
36%
1.5
US
CoStar Group Inc
NASDAQ:CSGP
265.7
77%
3.5
CH
SGS SA
SIX:SGSN
27.9
15%
1.9
US
Leidos Holdings Inc
NYSE:LDOS
14.3
9%
1.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Elixirr International PLC
LSE:ELIX
Average EV/EBITDA: 47.2
13
16%
0.8
UK
Relx PLC
LSE:REL
22
9%
2.4
CA
Thomson Reuters Corp
TSX:TRI
30.5
7%
4.4
IE
Experian PLC
LSE:EXPN
163.5
11%
14.9
US
Verisk Analytics Inc
NASDAQ:VRSK
29
9%
3.2
UK
I
IHS Markit Ltd
F:0M3
26.4
N/A N/A
NL
Wolters Kluwer NV
AEX:WKL
20.5
8%
2.6
US
Equifax Inc
NYSE:EFX
21.2
15%
1.4
US
CoStar Group Inc
NASDAQ:CSGP
170.1
90%
1.9
CH
SGS SA
SIX:SGSN
13.1
10%
1.3
US
Leidos Holdings Inc
NYSE:LDOS
10.5
5%
2.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Elixirr International PLC
LSE:ELIX
Average EV/EBIT: 577.8
15
16%
0.9
UK
Relx PLC
LSE:REL
28.1
13%
2.2
CA
Thomson Reuters Corp
TSX:TRI
42.6
9%
4.7
IE
Experian PLC
LSE:EXPN
229.8
16%
14.4
US
Verisk Analytics Inc
NASDAQ:VRSK
36.1
10%
3.6
UK
I
IHS Markit Ltd
F:0M3
39.5
N/A N/A
NL
Wolters Kluwer NV
AEX:WKL
27.3
10%
2.7
US
Equifax Inc
NYSE:EFX
35.1
24%
1.5
US
CoStar Group Inc
NASDAQ:CSGP
5 870.9
454%
12.9
CH
SGS SA
SIX:SGSN
20
13%
1.5
US
Leidos Holdings Inc
NYSE:LDOS
12
6%
2

See Also

Summary
ELIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ELIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ELIX stock valuation using valuation multiples.
Wall Street Estimates
ELIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ELIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 258,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.